TrialClinical pharmacology in drug development2022

Pharmacokinetics, Safety, and Pharmacodynamics of Romiplostim in Chinese Subjects With Immune Thrombocytopenia: A Phase I/II Trial.

Junyuan Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.